ArticleThe Journal of clinical investigation2023

Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti-PD-1 resistance.

Ashwin Ajith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.